Aamir Sheikh

Author
Aamir Sheikh

Aamir Sheikh

Author

Aamir is a tech journalist specializing in tech and crypto. He graduated from MAJ University, Karachi, with an MBA in Marketing and Finance. He has been writing cryptocurrency analysis for Cryptopolitan since 2021.


Author’s Articles

  • Is AI-Driven Automation Redefining Business Processes in 2024?

  • How Much Information Must We Entrust for Effective Personhood Verification?

  • Can Generative AI Search Offer a Better Alternative to Google?

  • Taiwanese AI Expert Warns of China’s Dominance in Information Warfare While U.S. Lags Behind

  • OpenAI Staff Granted Permission to Liquidate Shares at Astounding $86 Billion Valuation – Insider Report

  • Google’s Magika AI Goes Open Source – Empowering Cyber Defenders Against Malware Threats

  • Masayoshi Son’s Ambitious AI Chip Venture – Pursuing a $100 Billion Dream

  • Analyzing ChatGPT’s Traffic Decline and Its Implications for OpenAI

  • Google Rolls Out Free AI Tools to Safeguard Gmail, Google Drive – A Game-Changer in Cybersecurity

  • AI Investment Surge, Market Cap Milestones, and Enterprise Earnings Realities

  • What Does Korea’s First AI Forgery Case Reveal About Legal Document Security?

  • Is AI-Based Student Monitoring the Answer to Preventing Youth Suicide?

  • AI Enhances Protection Efforts in Daintree’s Smart Rainforest

  • Why is Google One Hiding Its 200GB Plan?

  • Tech Influencer Calls Out AI Company for Unauthorized Use of Likeness in Chatbot

  • Is Weaponizing AI the New Norm in Cyber Warfare? Insights from Microsoft and OpenAI

  • Campaign Ad Regulatory Bill Advances – Senate Approves AI Disclosure Mandate

  • Nvidia Surpasses Alphabet to Claim Third Spot on Wall Street Valuation Chart

  • AI in Neurological Diagnosis – Brain Death Declarations, Parkinson’s-Paraquat Links, and AI Advancements in ARIA Detection

  • Navigating Fraud in 2024 – Advanced Fraud Monitoring and Prevention Strategies

  • OpenAI Enhances ChatGPT with User Memory Feature for Personalized Interactions

  • FDA Expedites AI Integration for Drug Development AT SCOPE Summit